GlobeStar Therapeutics Corporation (GSTC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 20, 2025, 4:00 PM EDT
GlobeStar Therapeutics Market Cap
GlobeStar Therapeutics has a market cap or net worth of $1.24 thousand as of August 21, 2025. Its market cap has decreased by -99.93% in one year.
Market Cap
1.24K
Enterprise Value
331.38K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 23, 2016, GlobeStar Therapeutics's market cap has decreased from 1.06M to 1.24K, a decrease of -99.88%. That is a compound annual growth rate of -52.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 1.24K | -99.60% |
| Dec 31, 2024 | 310.28K | -66.41% |
| Dec 29, 2023 | 923.78K | -90.98% |
| Dec 30, 2022 | 10.25M | 47.12% |
| Dec 31, 2021 | 6.96M | 102.51% |
| Dec 31, 2020 | 3.44M | 427.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 626.52M |
| Elite Pharmaceuticals | 603.43M |
| CytoDyn | 363.56M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |